Novartis' programme providing free access to its spinal muscular atrophy (SMA) gene therapy Zolgensma is being scaled back to a dozen countries worldwide, according to the company. First introduced in ...
Reka API Examples with .NET C# This repository showcases how to use Reka Research and Reka Vision to build intelligent apps that can search the web, structure responses, and support reasoning. It’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback